Bruce Morland

Steelhouse Lane
Birmingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Liver resection extended to adjacent structures for advanced hepatoblastoma - a 25 year tertiary hepatobiliary and transplant center experience.

Liver resection extended to adjacent structures for advanced hepatoblastoma - a 25 year tertiary hepatobiliary and transplant center experience.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: July 31, 2025

Prognostic factors of early mortality in children and adolescents with relapsed/refractory solid tumors participating in dose-finding trials in the targeted and immune therapies era: An ITCC study.

Prognostic factors of early mortality in children and adolescents with relapsed/refractory solid tumors participating in dose-finding trials in the targeted and immune therapies era: An ITCC study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 26, 2025

Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.

Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 08, 2024

The RELIVE consortium for relapsed or refractory pediatric hepatoblastoma and hepatocellular carcinoma: a scoping review of the problem and a proposed solution.

The RELIVE consortium for relapsed or refractory pediatric hepatoblastoma and hepatocellular carcinoma: a scoping review of the problem and a proposed solution.

Journal: EClinicalMedicine

Published: September 01, 2023

Computational drug prediction in hepatoblastoma by integrating pan-cancer transcriptomics with pharmacological response.

Computational drug prediction in hepatoblastoma by integrating pan-cancer transcriptomics with pharmacological response.

Journal: Hepatology (Baltimore, Md.)

Published: June 09, 2023

Consensus classification of pediatric hepatocellular tumors: A report from the Children's Hepatic tumors International Collaboration (CHIC).

Consensus classification of pediatric hepatocellular tumors: A report from the Children's Hepatic tumors International Collaboration (CHIC).

Journal: Pediatric blood & cancer

Published: August 25, 2022

Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma.

Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma.

Journal: Molecular cancer therapeutics

Published: May 11, 2022

Lineage switching of the cellular distribution of BRAFV600E in multisystem Langerhans cell histiocytosis.

Lineage switching of the cellular distribution of BRAFV600E in multisystem Langerhans cell histiocytosis.

Journal: Blood advances

Published: November 30, 2021

Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment: An International Society of Paediatric Oncology Supportive Care Consensus Report.

Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment: An International Society of Paediatric Oncology Supportive Care Consensus Report.

Journal: JAMA oncology

Published: August 12, 2021

Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.

Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: June 04, 2021

Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)☆.

Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)☆.

Journal: ESMO open

Published: May 26, 2021

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆.

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: May 22, 2021

Showing 1-12 of 52

Last Updated: 09/26/2026